Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
04/05/2026 21:05
May 04 (Reuters) - ORIC Pharmaceuticals Q1 income from operations USD -39.619 million. Q1 net income USD -35.767 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows